Amides as sphingomyeline inhibitors

Details for Australian Patent Application No. 2007287819 (hide)

Owner Novartis AG

Inventors Billich, Andreas; Oberhauser, Berndt; Baumann, Karl

Agent Davies Collison Cave

Pub. Number AU-A-2007287819

PCT Pub. Number WO2008/022771

Priority 06119350.4 23.08.06 EP

Filing date 21 August 2007

Wipo publication date 28 February 2008

International Classifications

C07F 9/38 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/185 (2006.01) - Acids

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07C 309/24 (2006.01) Sulfonic acids

C07D 285/10 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/022771 Priority application(s): WO2008/022771

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007287820-Use of light sensitive genes

2007287816-Accessory